Inventor
TEEMU T. JUNTTILA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
C12NMicroorganisms or enzymes8%
PatentTitleYear
12,297,270Bispecific antigen-binding molecules and methods of use202512,030,947Humanized and affinity matured antibodies to FcRH5 and methods of use202411,866,498Bispecific antigen-binding molecules and methods of use202411,732,054Anti-CD3 antibodies and methods of use202311,530,275Anti-CD3 antibodies and methods of use202211,352,431Anti-FCRH5 antibodies202211,192,950Humanized and affinity matured antibodies to FcRH5 and methods of use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to GENENTECH INC (7)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |